Parima Daroui, M.D., Ph.D.

Parima Daroui, M.D., Ph.D., was motivated to pursue a career in medicine from an early age, after acting as primary caregiver to her mother. An associate clinical professor in City of Hope’s Department of Radiation Oncology, working with patients at the Temecula and Wildomar Radiation Oncology centers, Dr. Daroui specializes in the treatment of breast cancer with a compassionate and personalized approach, inspired by a desire to help patients in their journey to becoming cancer- and/or pain-free.

After completing her medial degree and her doctoral degree in cellular and molecular pharmacology, she trained and performed clinical research under the mentorship of world-renowned breast specialist Dr. Bruce Haffty.

Highly active in her field, Dr. Daroui has served as an expert moderator at the American Society for Radiation Oncology (ASTRO) annual conference and is an associate editor for Advances in Radiation Oncology. She also participates on the NRG Ancillary Study committee and the American Radium Society (ARS) and ASTRO breast cancer guideline committees. Recognized by her peers as a “top doctor – physician of excellence” for four years running, she has authored multiple publications, including a book chapter on ductal carcinoma in situ (DCIS) and several publications on techniques to improve outcomes for patients receiving radiation therapy.

Dr. Daroui speaks fluent Farsi, as well as some Italian and French.

AWARDS

• 2003 Gallo Award for Outstanding Cancer Research, The Cancer Institute of New Jersey
• 2002, Young Investigator Award, Department of Pharmacology
• Awarded DELF/DALF diplomas of advanced French proficiency

MEMBERSHIPS

• American Society of Radiation Oncology
• American Radium Society
• American Medical Association
• NRG Oncology

• Novick K, Chadha M, Daroui P, et al. “American Radium Society Appropriate Use Criteria ‘Postmastectomy Radiotherapy’ Executive Summary of Clinical Topics” International Journal of Radiation Oncology, Biology, Physics, 2023 Jul 20:S0360-3016(23)07638-1
• Deek M, Daroui P, Jabbour S. “Overexpression of Excision Repair Cross Complementing-1 Gene Associates with Higher Risk of Therapeutic Failure after Definitive Chemoradiation for Unresectable Non-Small Cell Lung Cancer” Annals of Palliative Medicine. 2021 Jul;10(7)
• Laoui S, Baldytchev M, Gonzales J, Dietrich S, Kuo J, Ramsinghani N, Daroui P, Farol H, Roa D. “Flattening filter free beam energy selection and its impact in multitarget intracranial stereotactic radiosurgery treatments” Medical Dosimetry, ePub June 13, 2020
• Wei W, Ionnides P, Sehgal V, Daroui P. “Quantifying the Impact of Optical Surface Guidance in the Treatment of Cancers of the Head and Neck” Journal of Applied Clinical Medical Physics, 2020 Jun;21(6):73-82
• Ponticorvo A, Rowland R, Adelusi S, Leproux A, Wei R, Kuo J, Daroui P, Ramsinghani N, Al-Ghazi M, Durkin A. "Using Spatial Frequency Domain Imaging (SFDI) to quantify physiological changes of patients undergoing radiotherapy for breast cancer treatment" Proc. SPIE 11211, Photonics in Dermatology and Plastic Surgery 2020, 20 February 2020
• Vuong W, Garg R, Bourgeois D, Yu S, Sehgal V, Daroui P. Dosimetric comparison of deep-inspiration breath-hold and free-breathing treatment delivery techniques for left-sided breast cancer using 3D surface tracking. Medical Dosimetry Med 2018 Aug 2. pii: S0958-3947(18)30078-5.
• Sindhu K, Armstrong W, Hasso A, Farzaneh T, Daroui P. “Recurrent squamous cell carcinoma involving cranial nerves in a patient with left glottic carcinoma treated with definitive radiation therapy: a case report” Practical Radiation Oncology, 2017 Mar-Apr; 7(2):100-102.
• Yu S, Sehgal V, Al-Ghazi M, Lawrenson L, Wei R, Kuo J, Daroui P, Ramsinghani N. “Response to Letter to the Editor: Regarding "The dosimetric impact of image guided radiation therapy by intratumoral fiducial markers" Practical Radiation Oncology 2017 Jan - Feb;7(1): e87
• Connor M, Wei R, Yu S, Sehgal V, Klempner S, Daroui P. “Radiation Dermatitis Caused by a Bolus Effect from an Abdominal Compression Device” Medical Dosimetry 2016;41(3):221-4.
• Yu S, Lawrenson L, Wei R, Sehgal V, Hanna N, Kuo J, Daroui P, Ramsinghani N, AlGhazi M. “The dosimetric impact of image guided radiation therapy by intratumoral fiducial markers” Practical Radiation Oncology. 2016 Jul-Aug;6(4):276-83
• Daroui P, Jabbour S, et al. “American College of Radiology (ACR) Appropriateness Criteria Resectable Stomach Cancer" Oncology, 2015 Aug;29(8):595-602
• Mayadev J, Einck J, Elson S, Rugo H, Hwang S, Bold R, Daroui P, McCloskey S, Yashar C, Kim D, Fowble B. “Practice Patterns in the Delivery of Post Mastectomy Radiation Therapy among the University of California Athena Breast Health Network” Clinical Breast Cancer, 2015 Feb;15(1):43-7